Valued at USD 848.6 million in 2020, the spirometer market is projected to reach USD 1.78 billion by 2028, growing at a CAGR of 10.1% during the forecast period 2021–2028. Major players include Schiller, Fukuda Sangyo Co. Ltd., Vyaire Medical, Inc., Nihon Kohden Corporation, Smiths Medical, nSpire Health Inc., SDI Diagnostics, Geratherm Respiratory AG, Vitalograph, and Koninklijke Philips N.V. Prominent factors boosting growth include the rising prevalence of respiratory disorders, an aging global population, favorable government policies promoting awareness, and the miniaturization of spirometers.

Rising Burden of Respiratory Disorders Supports the Spirometer Market

Approximately 2 billion individuals worldwide are exposed to air pollutants daily, and these harmful gases adversely affect the lungs. This exposure, combined with an aging population, underpins demand for spirometers. Government policies that raise awareness of the ill effects of respiratory disorders further support the industry, while companies introduce technologically advanced products that simplify the diagnosis process for physicians and medical professionals.

COPD Leads Application Demand

By application, the COPD segment held the largest revenue share in 2020 owing to rising COPD cases across the globe and significant government-based funding. According to CDC estimates cited in the report, the treatment cost for COPD in the US was expected to reach USD 90 billion by 2020. The application segmentation also covers asthma, cystic fibrosis, pulmonary fibrosis, and other conditions.

Browse Full Insights: https://www.polarismarketresearch.com/industry-analysis/spirometer-market

Adoption Challenges and Innovation

The use of spirometry for asthma in pediatric patients, particularly in resource-poor countries with a high burden of communicable diseases, remains low owing to high cost and the non-availability of technical staff. Companies are therefore employing strategies to increase adoption in low-income countries, and modern spirometry equipment standardizes results to provide quick responses. The rising economic burden of asthma and the emergence of innovative apps are also increasing adoption, with the UK-based NHS reporting annual spending of around USD 1 billion on asthma treatment.

Handheld Spirometers Gain Momentum in the Spirometer Market

Based on type, the tabletop segment held the largest share in 2020 because of its extensive use in diagnosing respiratory and other pulmonary disorders. However, handheld spirometers are expected to register a lucrative growth rate over the study period. These compact devices produce and store hundreds of diagnostic tests in digital form, and results can be transferred via flash drives as electronic medical records. Their ability to provide integrated insights supports informed clinical decisions.

Peak Flow Measurement and Home Healthcare

Within technology, flow measurement held a significant share in 2019, but peak flow measurement is expected to register the fastest growth over the forecast period. These devices can warn of the onset of an asthma attack by analyzing patterns of lung contraction, allowing patients to act on time. Meanwhile, the home healthcare end-use segment is expected to grow faster than hospitals and clinics, which held a significant share in 2019 owing to high patient admissions and the high cost of spirometers. Rising respiratory disease among the elderly and advancements in telemedicine and digital initiatives are cited as growth contributors for home healthcare.

Regional Outlook and Competitive Landscape

North America is the largest revenue contributor, followed by Europe and Asia Pacific. In 2019, the region accounted for over 40 percent of the global spirometer market, supported by high COPD prevalence, favorable government policies, and improvements in spirometer technology. Asia Pacific is expected to register a lucrative growth rate owing to improving primary healthcare facilities and strategies to manage chronic lung disorders. Companies are adopting innovative medical coatings to prevent infection and pursuing emerging nations to expand adoption.

Strategic Takeaways

For manufacturers and distributors, the segment view highlights compact, digitally enabled handheld devices, peak flow technology for asthma monitoring, and offerings suited to home-based care. High cost remains a restraint, as spirometer are costly instruments that only hospitals can easily afford.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market